Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence.
about
B Cell Therapy for Multiple Sclerosis: Entering an Era.Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report.Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
P2860
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence.
@ast
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence.
@en
type
label
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence.
@ast
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence.
@en
prefLabel
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence.
@ast
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence.
@en
P2093
P2860
P356
P1476
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence.
@en
P2093
Emad Fayyazi
Masoud Etemadifar
Mehdi Serati
Mehri Salari
Mozhde Askari
Omid Mirmosayyeb
Roham Nikkhah
P2860
P356
10.4103/1735-1995.200275
P577
2017-02-16T00:00:00Z